Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Aug 21, 2019 9:26 AM EDT Latest News August 15, 2019 European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis August 9, 2019 China National Medical Products Administration Approves Biktarvy® (Bictegravir, Emtricitabine and Tenofovir Alafenamide) for Treatment of HIV-1 Infection August 7, 2019 Gilead Sciences Statement on U.S. Food and Drug Administration Advisory Committee’s Recommendation on Descovy for PrEP™ View All Events Jul 30, 2019 at 4:30 PM EDT Second Quarter 2019 Gilead Sciences Earnings Conference Call Jul 14, 2019 at 3:00 PM EDT Gilead Sciences and Galapagos Global Collaboration Conference Call Jun 5, 2019 at 11:30 AM EDT Gilead Sciences at the Jefferies 2019 Healthcare Conference View All
